PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:44 AM ET

Sponsor Check › Person

AB
No photo found yet (own website and image search run after this page is viewed)

Ali Behbahani

Named as an officer, director or promoter on SEC Form D filings · MD, CA, MN, NJ, CO · Jun 2, 2011 → Jun 25, 2025

26deals (issuers)
$7.08Breported sold
877investors
68Form D filings
2011–2025years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:20 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Ali Behbahani is listed as an executive officer and director on 68 SEC Form D filings by 26 issuers between Mar 2010 and Mar 2026. Largest by amount reported sold: New Enterprise Associates 18, L.P. (Timonium, MD — pooled investment fund — 2021–2022; $2.85B reported sold to 271 investors), NEA 18 Venture Growth Equity, L.P. (Timonium, MD — pooled investment fund — 2021–2022; $2.33B reported sold to 244 investors), NEA Secondary Opportunity Fund, L.P. (Timonium, MD — pooled investment fund — 2024; $468.2M reported sold to 60 investors), NEA RP SPV, L.P. (Timonium, MD — pooled investment fund — 2024; $244.6M reported sold to 3 investors), NEA TS 2024 SPV, L.P. (Timonium, MD — pooled investment fund — 2024; $155M reported sold to 20 investors) and 21 more (all listed below).

What this means That is a lot of deals — 26 separate companies raised money with this person listed as executive officer and director, over about 16 years. Across those companies the filings report $7.08B sold in total.

Listed alongside Anthony A. Florence (16 shared filings), Mohamad Makhzoumi (16 shared filings), Paul E. Walker (16 shared filings), Scott Sandell (16 shared filings), Carmen Chang (15 shared filings) and 138 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Ali. Each name links to their own page.

The issuers belong to 3 sponsor groups: Nea (19 issuers, $10.96B reported sold, 2009–2025), Rotation (2 issuers, $12M reported sold, 2009–2016) and Nea (9 issuers, $0 reported sold, 2024–2026).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 1 bankruptcy case matching the name listed in Key records below.

What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared the newest 50 of 68 public filings for Ali Behbahani and found 12 differences, 2 worth asking the sponsor about: 4 bankruptcy cases name the subject or team members; 6 paid sellers are listed without a CRD number; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Ali Behbahani has not run yet — it is joining a line of 60,071 names; searches run around the clock at the hosts' allowed rate. Searched so far: 685 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:20 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Ali Behbahani..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

1 case: 1 closed (disposition not in docket feed)

Ali A. Behbahani and Afshan Behbahani closed
United States Bankruptcy Court, C.D. California · No. 8:09-bk-11287 · Filed Feb 18, 2009 · Closed Jul 29, 2009
Role of Ali A. Behbahani and Afshan Behbahani: Debtor · Outcome: Case closed 2009-07-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 7 federal dockets); first name matches; 3 people with this name in Form D filings; court in the person's filing state (CA)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:20 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

12 differences found between the filings for Ali Behbahani — 2 worth asking about (compared the newest 50 of 68 filings on Oct 24, 2026; older filings not covered)

Worth asking · Jan 8, 2004 – Aug 17, 2012

4 bankruptcy cases name the subject or team members

Bankruptcy case: Ali A. Behbahani and Afshan Behbahani — filed Feb 18, 2009 · Bankruptcy case: Christopher Shen and Yihsuan Ho — filed May 4, 2012 · Bankruptcy case: Roger Zhang — filed Mar 25, 2009 · Bankruptcy case: Chase Manhattan Bank USA v. Ozawa — filed Jan 8, 2004

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, C.D. California ↗Docket · United States Bankruptcy Court, C.D. California ↗Christopher Shen — PartnerFacts page ↗Docket · United States Bankruptcy Court, C.D. California ↗
Sources
Note · Mar 1, 2019 – Sep 6, 2019

Ali Behbahani appears on 2 deals that stopped filing before reaching their target

Nkarta, Inc. (last filing Sep 6, 2019; $43,899,296 sold of $114,636,678); New Enterprise Associates 17, L.P. (last filing Mar 1, 2019; $0 sold of $3,600,000,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Nkarta, Inc. — PartnerFacts page ↗New Enterprise Associates 17, L.P. — PartnerFacts page ↗
Sources
Worth asking · Nov 12, 2021 – May 24, 2022

6 paid sellers are listed without a CRD number

Paid seller listed without a CRD number: Lazard & Co., Limited — New Enterprise Associates 18, L.P. · Paid seller listed without a CRD number: Lazard & Co., Limited — NEA 18 Venture Growth Equity, L.P. · Paid seller listed without a CRD number: DS Investment & Securities Co., Ltd. — NEA 18 Venture Growth Equity, L.P. · Paid seller listed without a CRD number: DS Investment & Securities Co., Ltd. — New Enterprise Associates 18, L.P. · Paid seller listed without a CRD number: KakaoPay Securities Corp. — New Enterprise Associates 18, L.P. · and 1 more

What this means Without a CRD number we cannot look a seller up on BrokerCheck. Ask who they are and whether they are registered.

Form D/A · May 24, 2022 ↗BrokerCheck search: Lazard & Co., Limited ↗New Enterprise Associates 18, L.P. — PartnerFacts page ↗Form D/A · May 24, 2022 ↗
Sources
Note · Apr 1, 2022 – Apr 22, 2022

Form D filed 21 days after the first sale — FirstLight Bio, Inc.

The filing says the first sale was Apr 1, 2022. The Form D was filed Apr 22, 2022 — 21 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 6 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Apr 22, 2022 ↗FirstLight Bio, Inc. — PartnerFacts page ↗
Sources
Note · Jan 6, 2017 – Jan 23, 2017

Form D filed 17 days after the first sale — Ivantis, Inc.

The filing says the first sale was Jan 6, 2017. The Form D was filed Jan 23, 2017 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Jan 23, 2017 ↗Ivantis, Inc. — PartnerFacts page ↗
Sources
Note · May 31, 2016 – Jul 11, 2024

19 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — 858 Therapeutics, Inc. (latest filing Jul 11, 2024) · No amendment in the last 12 months on an offering that may still be open — SpyGlassPharma, Inc. (latest filing Jul 11, 2023) · No amendment in the last 12 months on an offering that may still be open — New Enterprise Associates 18, L.P. (latest filing May 24, 2022) · No amendment in the last 12 months on an offering that may still be open — NEA 18 Venture Growth Equity, L.P. (latest filing May 24, 2022) · No amendment in the last 12 months on an offering that may still be open — Cardionomic, Inc. (latest filing Oct 4, 2021) · and 14 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Jul 11, 2024 ↗858 Therapeutics, Inc. — PartnerFacts page ↗Form D · Jul 11, 2023 ↗SpyGlassPharma, Inc. — PartnerFacts page ↗
Sources
Note · Jun 14, 2016 – Jun 25, 2025

4 offerings changed their target amount between filings

Offering amount changed between filings — NEA SH SPV, L.P. · Offering amount changed between filings — NEA TS 2024 SPV, L.P. · Offering amount changed between filings — Arcellx, Inc. · Offering amount changed between filings — CVRx, Inc.

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · May 8, 2023 ↗Form D/A (later) · Jun 25, 2025 ↗NEA SH SPV, L.P. — PartnerFacts page ↗Form D (earlier) · Jun 20, 2024 ↗
Sources
Note · May 8, 2023 – Jun 25, 2025

Minimum investment changed between filings — NEA SH SPV, L.P.

The May 8, 2023 filing lists a minimum of $7,500,000; the Jun 25, 2025 Form D/A lists $12,500,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · May 8, 2023 ↗Form D/A (later) · Jun 25, 2025 ↗NEA SH SPV, L.P. — PartnerFacts page ↗
Sources
Note · Jan 24, 2025

Same name, different state: "Ali Behbahani" (WA) is a separate record

This page covers filings where the address state is MD or CA or MN or NJ or CO. A separate record, "Ali Behbahani" with address state WA, is listed on 1 filing — most recently by Tune Therapeutics, Inc. (Jan 24, 2025). Both records have filings in the same period (Jan 24, 2025).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Ali Behbahani (WA) — PartnerFacts page ↗Form D · Jan 24, 2025 ↗Tune Therapeutics, Inc. — PartnerFacts page ↗Ali Behbahani (MD,CA,MN,NJ,CO) — this page ↗
Sources
Note · Sep 6, 2016 – Dec 30, 2022

Same name, different state: "Ali Behbahani" (MA or V8 or NY) is a separate record

This page covers filings where the address state is MD or CA or MN or NJ or CO. A separate record, "Ali Behbahani" with address state MA or V8 or NY, is listed on 13 filings — most recently by Launchpad Therapeutics, Inc. (Dec 30, 2022). Both records have filings in the same period (Sep 6, 2016 to Dec 30, 2022).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Ali Behbahani (MA,V8,NY) — PartnerFacts page ↗Form D · Dec 30, 2022 ↗Launchpad Therapeutics, Inc. — PartnerFacts page ↗Ali Behbahani (MD,CA,MN,NJ,CO) — this page ↗
Sources
Note · Oct 25, 2017 – Jul 11, 2023

4 address changes between filings

Address moved from Mission Viejo, CA to Aliso Viejo, CA — SpyGlassPharma, Inc. · Address moved from Redwood City, CA to Santa Clara, CA — MINERVA SURGICAL INC · Address moved from Germantown, MD to Gaithersburg, MD — Arcellx, Inc. · Address moved from San Francisco, CA to Princeton, NJ — Oyster Point Pharma, Inc.

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D · Jan 5, 2021 ↗Form D · Jul 11, 2023 ↗SpyGlassPharma, Inc. — PartnerFacts page ↗Form D · Dec 4, 2019 ↗
Sources
Note · Jun 14, 2016 – Mar 27, 2026

Ali Behbahani is listed with 5 different address states: MN, CA, NJ, MD, CO

MN on 9 filings (Jun 14, 2016 to Oct 4, 2021); CA on 17 filings (Jan 23, 2017 to Jun 25, 2025); NJ on 1 filing (Feb 27, 2019); MD on 20 filings (Mar 1, 2019 to Jun 20, 2024); CO on 4 filings (Nov 21, 2022 to Mar 27, 2026).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Jun 14, 2016 ↗Form D · Jan 23, 2017 ↗Form D · Feb 27, 2019 ↗Form D · Mar 1, 2019 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. We compared the newest 50 of 68 filings (work cap); older filings are not covered here. As of Oct 24, 2026.

5. Money to insiders

4 of 53 offerings report sales commissions totalling $16,351,160; 1 reports finder's fees totalling $570,000; 1 reports proceeds to related persons totalling $360,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Mar 27, 2026 D/A
Nexo Therapeutics, Inc.
File 021-465438
$0$0$0None listed on this filingEDGAR ↗
Jun 25, 2025 D/A
NEA SH SPV, L.P.
File 021-481086
$0$0$0None listed on this filingEDGAR ↗
Jun 5, 2025 D
SpyGlassPharma, Inc.
File 021-548147
$0$0$0None listed on this filingEDGAR ↗
Aug 2, 2024 D/A
NEA TS 2024 SPV, L.P.
File 021-516399
$0$0$0None listed on this filingEDGAR ↗
Jul 18, 2024 D
NEA Secondary Opportunity Fund, L.P.
File 021-519116
$245,360$0$0 (est.)
An affiliate of the General Partner of the Issuer will receive a fee for management services based on a percentage of the Issuer's committed capital. Number of years to be paid and extent to be paid out of adjusted gross proceeds unknown at this time.
Jefferies LLC BrokerCheck CRD 2347 ↗EDGAR ↗
Jul 11, 2024 D
858 Therapeutics, Inc.
File 021-518431
$0$0$0None listed on this filingEDGAR ↗
May 21, 2024 D
NEA CH SPV, L.P.
File 021-513878
$0$0$0None listed on this filingEDGAR ↗
Feb 23, 2024 D
NEA RP SPV, L.P.
File 021-505950
$0$0$0None listed on this filingEDGAR ↗
Jul 11, 2023 D
SpyGlassPharma, Inc.
File 021-486492
$0$0$0None listed on this filingEDGAR ↗
Feb 6, 2023 D
Arcellx, Inc.
File 021-472689
$0$0$0None listed on this filingEDGAR ↗
May 24, 2022 D/A
New Enterprise Associates 18, L.P.
File 021-420874
$3,403,250 (est.)$0$0 (est.)
An affiliate of the General Partner of the Issuer will receive a fee for management services based on a percentage of the Issuer's committed capital. Number of years to be paid and extent to be paid out of adjusted gross proceeds unknown at this time.
Goldman Sachs & Co. LLC BrokerCheck CRD 361 ↗
Lazard Freres & Co. LLC BrokerCheck CRD 2528 ↗
Lazard & Co., Limited no CRD number reported
J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗
DS Investment & Securities Co., Ltd. no CRD number reported		EDGAR ↗
May 24, 2022 D/A
NEA 18 Venture Growth Equity, L.P.
File 021-420921
$12,652,550 (est.)$0$0 (est.)
An affiliate of the General Partner of the Issuer will receive a fee for management services based on a percentage of the Issuer's committed capital. Number of years to be paid and extent to be paid out of adjusted gross proceeds unknown at this time.
Goldman Sachs & Co. LLC BrokerCheck CRD 361 ↗
Lazard Freres & Co. LLC BrokerCheck CRD 2528 ↗
Lazard & Co., Limited no CRD number reported
J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗
DS Investment & Securities Co., Ltd. no CRD number reported		EDGAR ↗
Apr 22, 2022 D
FirstLight Bio, Inc.
File 021-442932
$0$0$0None listed on this filingEDGAR ↗
Mar 10, 2022 D
Arcellx, Inc.
File 021-436730
$0$0$0None listed on this filingEDGAR ↗
Oct 4, 2021 D
Cardionomic, Inc.
File 021-415541
$0$0$0
Excludes normal compensation for officers.
None listed on this filingEDGAR ↗
Jul 1, 2021 D/A
Arcellx, Inc.
File 021-395298
$0$570,000$0Solebury Capital LLC BrokerCheck CRD 143299 ↗EDGAR ↗
May 18, 2021 D
858 Therapeutics, Inc.
File 021-399747
$0$0$0None listed on this filingEDGAR ↗
Jan 5, 2021 D
SpyGlassPharma, Inc.
File 021-385257
$0$0$0None listed on this filingEDGAR ↗
Sep 4, 2020 D
NEA BH SPV II, L.P.
File 021-374899
$0$0$0None listed on this filingEDGAR ↗
Jul 8, 2020 D
CVRx, Inc.
File 021-370508
$0$0$0None listed on this filingEDGAR ↗
May 26, 2020 D
MINERVA SURGICAL INC
File 021-367681
$0$0$0None listed on this filingEDGAR ↗
Feb 21, 2020 D
Cardionomic, Inc.
File 021-361100
$0$0$0
Excludes normal compensation for officers.
None listed on this filingEDGAR ↗
Dec 19, 2019 D
NEA BH SPV, L.P.
File 021-355891
$0$0$0None listed on this filingEDGAR ↗
Dec 4, 2019 D
MINERVA SURGICAL INC
File 021-354743
$0$0$0None listed on this filingEDGAR ↗
Oct 15, 2019 D/A
Arcellx, Inc.
File 021-347172
$0$0$0None listed on this filingEDGAR ↗
Sep 6, 2019 D
Nkarta, Inc.
File 021-348219
$0$0$0None listed on this filingEDGAR ↗
Jun 5, 2019 D
SpyGlassPharma, Inc.
File 021-341181
$0$0$0None listed on this filingEDGAR ↗
May 31, 2019 D/A
CVRx, Inc.
File 021-264929
$0$0$0None listed on this filingEDGAR ↗
May 16, 2019 D
MINERVA SURGICAL INC
File 021-339780
$0$0$0None listed on this filingEDGAR ↗
Mar 1, 2019 D
New Enterprise Associates 17, L.P.
File 021-333845
$0$0$0 (est.)
An affiliate of the General Partner of the Issuer will receive a fee for management services based on a percentage of the Issuer's committed capital. Number of years to be paid and extent to be paid out of adjusted gross proceeds unknown at this time.
None listed on this filingEDGAR ↗
Feb 27, 2019 D
Oyster Point Pharma, Inc.
File 021-333703
$0$0$0None listed on this filingEDGAR ↗
Jan 4, 2019 D
MINERVA SURGICAL INC
File 021-329621
$0$0$0None listed on this filingEDGAR ↗
Apr 30, 2018 D
Cardionomic, Inc.
File 021-311249
$0$0$0
Excludes normal compensation for officers.
None listed on this filingEDGAR ↗
Mar 13, 2018 D
MINERVA SURGICAL INC
File 021-307556
$0$0$0None listed on this filingEDGAR ↗
Oct 25, 2017 D
Oyster Point Pharma, Inc.
File 021-297412
$0$0$0None listed on this filingEDGAR ↗
Jan 23, 2017 D
Ivantis, Inc.
File 021-278940
$0$0$0None listed on this filingEDGAR ↗
Aug 9, 2016 D
ROTATION MEDICAL INC
File 021-268554
$0$0$0
Excludes standard compensation for officers.
None listed on this filingEDGAR ↗
Jan 8, 2016 D
MINERVA SURGICAL INC
File 021-254790
$0$0$0None listed on this filingEDGAR ↗
Oct 16, 2015 D
Cardionomic, Inc.
File 021-249544
$0$0$0
Excludes normal compensation for officers.
None listed on this filingEDGAR ↗
Oct 14, 2014 D/A
Ivantis, Inc.
File 021-191569
$0$0$0None listed on this filingEDGAR ↗
Oct 2, 2014 D
Adaptimmune Ltd
File 021-225667
$0$0$0None listed on this filingEDGAR ↗
Sep 22, 2014 D
MINERVA SURGICAL INC
File 021-225123
$0$0$0None listed on this filingEDGAR ↗
Jul 10, 2014 D
ROTATION MEDICAL INC
File 021-220679
$0$0$0
Excludes normal compensation for officers.
None listed on this filingEDGAR ↗
Mar 18, 2014 D
Oculeve, Inc.
File 021-213802
$0$0$0None listed on this filingEDGAR ↗
Jul 15, 2013 D
CVRx, Inc.
File 021-199681
$50,000$0$0Piper Jaffray & Co. BrokerCheck CRD 665 ↗
via Piper Jaffray & Co. (CRD 665 ↗)
EDGAR ↗
Jun 5, 2013 D
ROTATION MEDICAL INC
File 021-197480
$0$0$0
Excludes normal compensation for officers.
None listed on this filingEDGAR ↗
Mar 20, 2013 D/A
Oculeve, Inc.
File 021-186287
$0$0$0None listed on this filingEDGAR ↗
Dec 21, 2012 D
MINERVA SURGICAL INC
File 021-188864
$0$0$0None listed on this filingEDGAR ↗
Sep 21, 2011 D
Prospex Medical III, Inc.
File 021-166174
$0$0$360,000 (est.)
The proceeds from the offering will be used for working capital and general business purposes, which includes payment of Mr. Atkinson's salary as an employee of the company.
None listed on this filingEDGAR ↗
Jun 2, 2011 D
MINERVA SURGICAL INC
File 021-160714
$0$0$0None listed on this filingEDGAR ↗
Apr 14, 2011 D
ROTATION MEDICAL INC
File 021-158374
$0$0$0
Excludes normal compensation to officers.
None listed on this filingEDGAR ↗
Apr 15, 2010 D
Denali Medical II, Inc.
File 021-140685
$0$0$0
Excludes normal compensation to officers.
None listed on this filingEDGAR ↗
Mar 18, 2010 D
ROTATION MEDICAL INC
File 021-99328
$0$0$0
Excludes normal compensation to officers.
None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 26

Every issuer that named Ali Behbahani on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

NT
Biotechnology

Nexo Therapeutics, Inc.

Littleton, CO · Nov 21, 2022 → Mar 27, 2026 · 4 filings
  • Mar 27, 2026 · D/A · $60,000,000 sold of $60,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 17, 2025 · D/A · $52,500,001 sold of $60,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 13, 2024 · D/A · $45,000,000 sold of $60,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 21, 2022 · D · $30,000,000 sold of $60,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $60M from 7 investors (100% of the $60M target) as of the latest filing. Ali is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

NS
Pooled Investment Fund · group: Nea

NEA SH SPV, L.P.

Timonium, MD · May 8, 2023 → Jun 25, 2025 · 2 filings
  • Jun 25, 2025 · D/A · $12,500,000 sold of $12,500,000 · 1 investors · min. $12,500,000 · role: Executive Officer (Manager of the General Partner.) EDGAR ↗
  • May 8, 2023 · D · $7,500,000 sold of $7,500,000 · 1 investors · min. $7,500,000 · role: Executive Officer (Manager of the General Partner.) EDGAR ↗

Raised $12.5M from 1 investor (100% of the $12.5M target) as of the latest filing. Ali is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

S
Other Health Care

SpyGlassPharma, Inc.

Aliso Viejo, CA · Jun 5, 2019 → Jun 5, 2025 · 4 filings
  • Jun 5, 2025 · D · $74,999,989 sold of $74,999,989 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 11, 2023 · D · $40,009,993 sold of $90,019,986 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 5, 2021 · D · $13,749,996 sold of $37,499,996 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 5, 2019 · D · $6,032,351 sold of $6,032,351 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $75M from 10 investors (100% of the $75M target) as of the latest filing. Ali is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

NT
Pooled Investment Fund · group: Nea

NEA TS 2024 SPV, L.P.

Timonium, MD · Jun 20, 2024 → Aug 2, 2024 · 2 filings
  • Aug 2, 2024 · D/A · $155,000,000 sold of $155,000,000 · 20 investors · min. $370,000 · role: Executive Officer (Manager of the General Partner.) EDGAR ↗
  • Jun 20, 2024 · D · $78,000,000 sold of $140,000,000 · 11 investors · min. $370,000 · role: Executive Officer (Manager of the General Partner.) EDGAR ↗

Raised $155M from 20 investors (100% of the $155M target) as of the latest filing. Ali is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

NS
Pooled Investment Fund · group: Nea

NEA Secondary Opportunity Fund, L.P.

Timonium, MD · Jul 18, 2024
  • Jul 18, 2024 · D · $468,203,512 sold of $468,203,512 · 60 investors · min. $10,482 · role: Executive Officer (Manager of the GP LLC.) EDGAR ↗

Raised $468.2M from 60 investors (100% of the $468.2M target) as of the latest filing. Ali is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

8T
Pharmaceuticals

858 Therapeutics, Inc.

San Diego, CA · May 18, 2021 → Jul 11, 2024 · 2 filings
  • Jul 11, 2024 · D · $25,175,501 sold of $50,350,497 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 18, 2021 · D · $20,000,001 sold of $39,999,996 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $25.2M from 12 investors (50% of the $50.4M target) as of the latest filing. Ali is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

NC
Pooled Investment Fund · group: Nea

NEA CH SPV, L.P.

Timonium, MD · May 21, 2024
  • May 21, 2024 · D · $65,000,000 sold of $65,000,000 · 20 investors · min. $21,455 · role: Executive Officer (Manager of the General Partner.) EDGAR ↗

Raised $65M from 20 investors (100% of the $65M target) as of the latest filing. Ali is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

NR
Pooled Investment Fund · group: Nea

NEA RP SPV, L.P.

Timonium, MD · Feb 23, 2024
  • Feb 23, 2024 · D · $244,570,000 sold of $244,570,000 · 3 investors · min. $44,570,000 · role: Executive Officer (Manager of the General Partner.) EDGAR ↗

Raised $244.6M from 3 investors (100% of the $244.6M target) as of the latest filing. Ali is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

A
Biotechnology

Arcellx, Inc.

Gaithersburg, MD · Aug 22, 2019 → Feb 6, 2023 · 6 filings
  • Feb 6, 2023 · D · $100,000,003 sold of $100,000,003 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 10, 2022 · D · $9,999,986 sold of $9,999,986 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 1, 2021 · D/A · $120,000,023 sold of $120,000,023 · 32 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 9, 2021 · D · $115,000,023 sold of $115,000,023 · 31 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 15, 2019 · D/A · $42,840,613 sold of $83,681,224 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 22, 2019 · D · $41,840,613 sold of $83,681,224 · 17 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $120M from 32 investors (100% of the $100M target) as of the latest filing. Ali is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

NE
Pooled Investment Fund · group: Nea

New Enterprise Associates 18, L.P.

Timonium, MD · Nov 12, 2021 → May 24, 2022 · 3 filings
  • May 24, 2022 · D/A · $2,845,331,500 sold of $2,900,000,000 · 271 investors · min. No minimum reported · role: Executive Officer (Manager of the GP LLC.) EDGAR ↗
  • Jan 21, 2022 · D/A · $1,668,396,000 sold of $2,900,000,000 · 128 investors · min. No minimum reported · role: Executive Officer (Manager of the GP LLC.) EDGAR ↗
  • Nov 12, 2021 · D · $0 sold of $2,900,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (Manager of the GP LLC.) EDGAR ↗

Raised $2.85B from 271 investors (98% of the $2.9B target) as of the latest filing. Ali is listed as executive officer on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

N1
Pooled Investment Fund · group: Nea

NEA 18 Venture Growth Equity, L.P.

Timonium, MD · Nov 12, 2021 → May 24, 2022 · 3 filings
  • May 24, 2022 · D/A · $2,328,808,500 sold of $3,700,000,000 · 244 investors · min. No minimum reported · role: Executive Officer (Manager of the GP LLC.) EDGAR ↗
  • Jan 21, 2022 · D/A · $1,217,204,000 sold of $3,700,000,000 · 115 investors · min. No minimum reported · role: Executive Officer (Manager of the GP LLC.) EDGAR ↗
  • Nov 12, 2021 · D · $0 sold of $3,700,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (Manager of the GP LLC.) EDGAR ↗

Raised $2.33B from 244 investors (63% of the $3.7B target) as of the latest filing. Ali is listed as executive officer on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

FB
Biotechnology

FirstLight Bio, Inc.

New York, NY · Apr 22, 2022
  • Apr 22, 2022 · D · $25,374,795 sold of $25,374,795 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $25.4M from 10 investors (100% of the $25.4M target) as of the latest filing. Ali is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

C
Other Health Care

Cardionomic, Inc.

New Brighton, MN · Oct 16, 2015 → Oct 4, 2021 · 4 filings
  • Oct 4, 2021 · D · $5,000,000 sold of $11,482,000 · 4 investors · min. $1 · role: Director EDGAR ↗
  • Feb 21, 2020 · D · $15,846,008 sold of $16,846,008 · 4 investors · min. $1 · role: Director EDGAR ↗
  • Apr 30, 2018 · D · $8,999,998 sold of $9,608,527 · 4 investors · min. $1 · role: Director EDGAR ↗
  • Oct 16, 2015 · D · $21,832,557 sold of $21,832,557 · 12 investors · min. $1 · role: Director EDGAR ↗

Raised $21.8M from 12 investors (100% of the $11.5M target) as of the latest filing. Ali is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

NB
Pooled Investment Fund · group: Nea

NEA BH SPV II, L.P.

Timonium, MD · Sep 4, 2020
  • Sep 4, 2020 · D · $67,323,002 sold of $67,323,002 · 29 investors · min. $55,000 · role: Executive Officer (Manager of the General Partner.) EDGAR ↗

Raised $67.3M from 29 investors (100% of the $67.3M target) as of the latest filing. Ali is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

C
Other Health Care

CVRx, Inc.

Minneapolis, MN · Jul 15, 2013 → Jul 8, 2020 · 6 filings
  • Jul 8, 2020 · D · $50,000,000 sold of $50,000,000 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 31, 2019 · D/A · $75,350,000 sold of $93,000,000 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 31, 2018 · D/A · $57,700,000 sold of $93,000,000 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 31, 2017 · D/A · $57,700,000 sold of $93,000,000 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 14, 2016 · D · $46,508,722 sold of $85,000,000 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 15, 2013 · D · $29,626,352 sold of $45,000,000 · 12 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $75.3M from 21 investors (100% of the $50M target) as of the latest filing. Ali is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MS
Other Health Care

MINERVA SURGICAL INC

Santa Clara, CA · Jun 2, 2011 → May 26, 2020 · 9 filings
  • May 26, 2020 · D · $15,000,000 sold of $30,000,000 · 14 investors · min. $1 · role: Director EDGAR ↗
  • Dec 4, 2019 · D · $10,000,000 sold of $10,500,000 · 16 investors · min. $1 · role: Director EDGAR ↗
  • May 16, 2019 · D · $10,228,734 sold of $10,500,000 · 25 investors · min. $1 · role: Director EDGAR ↗
  • Jan 4, 2019 · D · $9,200,757 sold of $10,000,000 · 17 investors · min. $1 · role: Director EDGAR ↗
  • Mar 13, 2018 · D · $10,000,000 sold of $20,000,000 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 8, 2016 · D · $15,000,000 sold of $15,000,000 · 25 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 22, 2014 · D · $25,519,660 sold of $25,525,500 · 26 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 21, 2012 · D · $19,999,999 sold of $19,999,999 · 19 investors · min. $1 · role: Director EDGAR ↗
  • Jun 2, 2011 · D · $26,171,656 sold of $26,180,000 · 19 investors · min. $1 · role: Director EDGAR ↗

Raised $26.2M from 26 investors (87% of the $30M target) as of the latest filing. Ali is listed as director on 9 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

NB
Pooled Investment Fund · group: Nea

NEA BH SPV, L.P.

Timonium, MD · Dec 19, 2019
  • Dec 19, 2019 · D · $129,300,000 sold of $129,300,000 · 17 investors · min. $800,000 · role: Executive Officer (Manager of the General Partner.) EDGAR ↗

Raised $129.3M from 17 investors (100% of the $129.3M target) as of the latest filing. Ali is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

N
Biotechnology

Nkarta, Inc.

South San Francisco, CA · Sep 6, 2019
  • Sep 6, 2019 · D · $43,899,296 sold of $114,636,678 · 13 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $43.9M from 13 investors (38% of the $114.6M target) as of the latest filing. Ali is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

NE
Pooled Investment Fund · group: Nea

New Enterprise Associates 17, L.P.

Timonium, MD · Mar 1, 2019
  • Mar 1, 2019 · D · $0 sold of $3,600,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (Manager of the GP LLC.) EDGAR ↗

No sales reported yet as of the latest filing. Ali is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

OP
Pharmaceuticals

Oyster Point Pharma, Inc.

Princeton, NJ · Oct 25, 2017 → Feb 27, 2019 · 2 filings
  • Feb 27, 2019 · D · $84,999,985 sold of $92,999,999 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 25, 2017 · D · $28,614,800 sold of $43,125,784 · 8 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $85M from 8 investors (91% of the $93M target) as of the latest filing. Ali is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

I
Other Technology

Ivantis, Inc.

Irvine, CA · Oct 14, 2014 → Jan 23, 2017 · 2 filings
  • Jan 23, 2017 · D · $25,000,002 sold of $25,000,002 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 14, 2014 · D/A · $58,869,998 sold of $71,370,003 · 14 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $58.9M from 14 investors (100% of the $25M target) as of the latest filing. Ali is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

RM
Other Health Care · group: Rotation

ROTATION MEDICAL INC

Plymouth, MN · Mar 18, 2010 → Aug 9, 2016 · 5 filings
  • Aug 9, 2016 · D · $8,000,000 sold of $8,000,000 · 13 investors · min. $1 · role: Director EDGAR ↗
  • Jul 10, 2014 · D · $21,720,434 sold of $21,720,434 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 5, 2013 · D · $5,500,744 sold of $5,500,744 · 9 investors · min. $1 · role: Director EDGAR ↗
  • Apr 14, 2011 · D · $10,000,000 sold of $15,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 18, 2010 · D · $3,880,000 sold of $4,411,973 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $21.7M from 14 investors (100% of the $8M target) as of the latest filing. Ali is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

A
Biotechnology

Adaptimmune Ltd

Abingdon, Oxfordshire, United Kingdom (as filed: X0) · Oct 2, 2014
  • Oct 2, 2014 · D · $103,809,789 sold of $103,809,789 · 22 investors · min. $1 · role: Director EDGAR ↗

Raised $103.8M from 22 investors (100% of the $103.8M target) as of the latest filing. Ali is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

O
Other Health Care

Oculeve, Inc.

South San Francisco, CA · Oct 30, 2012 → Mar 18, 2014 · 3 filings
  • Mar 18, 2014 · D · $16,649,997 sold of $16,649,997 · 8 investors · min. $1 · role: Director EDGAR ↗
  • Mar 20, 2013 · D/A · $7,590,476 sold of $7,592,976 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 30, 2012 · D · $7,565,476 sold of $7,565,476 · 8 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $16.6M from 9 investors (100% of the $16.6M target) as of the latest filing. Ali is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

PM
Biotechnology

Prospex Medical III, Inc.

White Bear Lake, MN · Sep 21, 2011
  • Sep 21, 2011 · D · $1,500,000 sold of $4,000,000 · 1 investors · min. $1,500,000 · role: Director EDGAR ↗

Raised $1.5M from 1 investor (38% of the $4M target) as of the latest filing. Ali is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

DM
Biotechnology · group: Rotation

Denali Medical II, Inc.

Plymouth, MN · Apr 15, 2010
  • Apr 15, 2010 · D · $4,000,000 sold of $4,600,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $4M from 1 investor (87% of the $4.6M target) as of the latest filing. Ali is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (2)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Ali Behbahani — MA, Switzerland (as filed: V8), NY, 6 issuers, Sep 6, 2016 → Dec 30, 2022 · no shared issuer
  • Ali Behbahani — WA, 1 issuer, Jan 24, 2025 → Jan 24, 2025 · no shared issuer

People around Ali 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

NP
Management entity

NEA Partners 18 VGE, L.P.

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

N1
Management entity

NEA 18 VGE GP, LLC

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

NP
Management entity

NEA Partners 18, L.P.

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

N1
Management entity

NEA 18 GP, LLC

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

NB
Management entity

NEA BH SPV GP, LLC

Executive Officer · 2 shared filings (2 issuers)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

NS
Management entity

NEA SH SPV GP, LLC

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

NT
Management entity

NEA TS 2024 SPV GP, LLC

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

N1
Management entity

NEA 17 GP, LLC

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

NP
Management entity

NEA Partners 17, L.P.

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

NR
Management entity

NEA RP SPV GP, LLC

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

NC
Management entity

NEA CH SPV GP, LLC

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

NS
Management entity

NEA SOF GP, LLC

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

NP
Management entity

NEA Partners SOF, L.P.

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Mohamad Makhzoumi

Executive Officer · 16 shared filings (10 issuers) · also on 16 other issuers

Mohamad Makhzoumi is on 26 issuers in total — a repeat sponsor. Their page lists every one.

AF
No photo found yet (own website and image search run after this page is viewed)
Person

Anthony A. Florence

Executive Officer · 16 shared filings (10 issuers) · also on 9 other issuers

Anthony A. Florence is on 19 issuers in total — a repeat sponsor. Their page lists every one.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Sandell

Executive Officer · 16 shared filings (10 issuers) · also on 30 other issuers

Scott Sandell is on 40 issuers in total — a repeat sponsor. Their page lists every one.

PW
No photo found yet (own website and image search run after this page is viewed)
Person

Paul E. Walker

Executive Officer · 16 shared filings (10 issuers) · also on 2 other issuers

Paul E. Walker is on 12 issuers in total — a repeat sponsor. Their page lists every one.

RY
No photo found yet (own website and image search run after this page is viewed)
Person

Rick Yang

Executive Officer · 15 shared filings (9 issuers) · also on 9 other issuers

Rick Yang is on 18 issuers in total — a repeat sponsor. Their page lists every one.

CC
No photo found yet (own website and image search run after this page is viewed)
Person

Carmen Chang

Executive Officer · 15 shared filings (9 issuers) · also on 2 other issuers

Carmen Chang is on 11 issuers in total — a repeat sponsor. Their page lists every one.

EM
No photo found yet (own website and image search run after this page is viewed)
Person

Edward T. Mathers

Executive Officer · 12 shared filings (8 issuers) · also on 1 other issuer

Edward T. Mathers is on 9 issuers in total — a repeat sponsor. Their page lists every one.

JN
No photo found yet (own website and image search run after this page is viewed)
Person

John Nehra

Director · 11 shared filings (5 issuers) · also on 11 other issuers

John Nehra is on 16 issuers in total — a repeat sponsor. Their page lists every one.

PS
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Sonsini

Executive Officer · 9 shared filings (5 issuers) · also on 27 other issuers

Peter Sonsini is on 32 issuers in total — a repeat sponsor. Their page lists every one.

MD
No photo found yet (own website and image search run after this page is viewed)
Person

Michael DeMane

Director · 9 shared filings (3 issuers) · also on 2 other issuers

Michael DeMane is on 5 issuers in total — a repeat sponsor. Their page lists every one.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

David Clapper

Executive Officer, Director · 9 shared filings (1 issuer) · also on 6 other issuers

David Clapper is on 7 issuers in total — a repeat sponsor. Their page lists every one.

RP
No photo found yet (own website and image search run after this page is viewed)
Person

Rodney Perkins

Director · 9 shared filings (1 issuer) · also on 6 other issuers

Rodney Perkins is on 7 issuers in total — a repeat sponsor. Their page lists every one.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

Bruno Strul

Director, Executive Officer · 9 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

RJ
No photo found yet (own website and image search run after this page is viewed)
Person

Ross Jaffe

Director · 9 shared filings (1 issuer) · also on 12 other issuers

Ross Jaffe is on 13 issuers in total — a repeat sponsor. Their page lists every one.

DA
No photo found yet (own website and image search run after this page is viewed)
Person

David C. Auth

Director · 8 shared filings (1 issuer) · also on 4 other issuers

David C. Auth is on 5 issuers in total — a repeat sponsor. Their page lists every one.

CT
No photo found yet (own website and image search run after this page is viewed)
Person

Csaba Truckai

Director · 8 shared filings (1 issuer) · also on 6 other issuers

Csaba Truckai is on 7 issuers in total — a repeat sponsor. Their page lists every one.

AC
No photo found yet (own website and image search run after this page is viewed)
Person

Albert Cha

Director · 7 shared filings (1 issuer) · also on 18 other issuers

Albert Cha is on 19 issuers in total — a repeat sponsor. Their page lists every one.

AG
No photo found yet (own website and image search run after this page is viewed)
Person

Albert Graf

Director · 7 shared filings (3 issuers)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

Jill Carroll

Director · 7 shared filings (2 issuers) · also on 3 other issuers

Jill Carroll is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Slattery

Director · 6 shared filings (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

John Brintnall

Executive Officer · 6 shared filings (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

NY
No photo found yet (own website and image search run after this page is viewed)
Person

Nadim Yared

Executive Officer, Director · 6 shared filings (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

DD
No photo found yet (own website and image search run after this page is viewed)
Person

Dean Bruhn-Ding

Executive Officer · 6 shared filings (1 issuer)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

LG
No photo found yet (own website and image search run after this page is viewed)
Person

Liza K. Landsman Gold

Executive Officer · 6 shared filings (2 issuers)

Listed on the same filings as Ali Behbahani. Their page shows their other deals.

GP
No photo found yet (own website and image search run after this page is viewed)
Person

Geoff Pardo

Director · 5 shared filings (2 issuers) · also on 10 other issuers

Geoff Pardo is on 12 issuers in total — a repeat sponsor. Their page lists every one.

TB
No photo found yet (own website and image search run after this page is viewed)
Person

Tara Butler

Director · 5 shared filings (2 issuers) · also on 10 other issuers

Tara Butler is on 12 issuers in total — a repeat sponsor. Their page lists every one.

TA
No photo found yet (own website and image search run after this page is viewed)
Person

Tiba Aynechi

Director · 5 shared filings (2 issuers) · also on 9 other issuers

Tiba Aynechi is on 11 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

N
Sponsor group

Nea

19 issuers · 27 filings · $10.96B reported sold · 2009–2025

One team, 19 deal companies. Ali Behbahani is listed on 9 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Ali Behbahani.

R
Sponsor group

Rotation

2 issuers · 7 filings · $12M reported sold · 2009–2016

One team, 2 deal companies. Ali Behbahani is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Ali Behbahani.

N
Sponsor group

Nea

9 issuers · 10 filings · $0 reported sold · 2024–2026

One team, 9 deal companies. Ali Behbahani is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Ali Behbahani.

Same business address

26 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); KY (Kentucky Secretary of State — Business Entity Search (sosbes.sos.ky.gov), searched by issuer name, data as of Oct 24, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

A person is never an adviser firm. 1 of the 26 issuers this person is listed on matches a Form ADV adviser (searched 24,962 advisers as of Oct 2, 2026): NEA RP SPV, L.P..

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Ali Behbahani by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 26 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Ali Behbahani is listed on: none on file. No website or social profile named in NEA Secondary Opportunity Fund, L.P.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #94,720 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Timonium, MD). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Maryland Judiciary case search ↗California — find the county court ↗Los Angeles Superior Court case search ↗Minnesota court records online ↗New Jersey state courts — find the court ↗Colorado state courts — find the court ↗New York WebCivil Supreme ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Maryland Secretary of State business search ↗California Secretary of State business search ↗Minnesota Secretary of State business search ↗New Jersey Secretary of State business search ↗Colorado Secretary of State business search ↗New York Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Ali Behbahani appears on a new Form D, or when a court case or SEC action is matched to them. See plans →